SOURCE: Research and Markets

Research and Markets

March 16, 2016 08:25 ET

Connected Drug Injection Devices to 2020

What Therapeutic Areas Are the Current Focus of Connected Devices?

DUBLIN, IRELAND--(Marketwired - March 16, 2016) - Research and Markets has announced the addition of the "Connected Drug Injection Devices" report to their offering.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.

Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn:

  • What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
  • What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
  • What therapeutic areas are the current focus of connected devices?
  • Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
  • What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
  • What does the current market for connected drug injection devices look like? What will it look like in 2020?
  • What are the key market drivers for the growth of connected injection devices?

Who Should Read This Report:


  • Drug Developers
  • Device Suppliers
  • CMOs
  • Components/APIs
  • Testing/Validation
  • Clinical Trial Mgmt


  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management
  • Consultants


  • Clinical Managers
  • Drug Distributors
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. Connected Devices -- The Opportunity
- Injectable Drug Development Trends
- The Rapid Rise of Prefilled Injection Devices
- Factors Driving Drug Self-Administration
- Therapeutic Demand Drivers
- The Impact of Developing Economies

3. Connectivity Technologies
- Wireless Technologies
- Bluetooth
- Cellular
- Near Field Communications
- Wired Technologies

4. Connected Devices

5. Wearable Devices
- Connected Autoinjectors
- Non-drug Specific Connected Injectors
- Self-powered Devices
- Automated Connected Injectors
- Vendor-specific Connectivity Platforms

6. Third Party Connectivity Devices

7. Near-term Markets for Connected Injection Devices
- Anaphylaxis
- Autoimmune Disease
- Cardiovascular
- Diabetes
- Hormone Replacement

8. Market Factors
- Regulatory Requirements
- Data Security
- Patient Acceptance

9. Company Profiles

For more information visit

Sector: Infusions and InjectablesNeedles and Syringes

Image Available:

Contact Information

  • Research and Markets
    Laura Wood
    Senior Manager

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716